Correcting the Myth of Calcium Correction

By Dr. Janet Simons on June 26, 2019

By Dr. Janet Simons (biography, no disclosures)

What gap I have noticed

Calcium levels are commonly ordered in both primary and acute care in patients with a variety of signs and symptoms. Hypocalcemia (total calcium concentrations generally below 2.0 mmol/L or ionized calcium below 1.15 mmol/l) is usually related to dietary deficiencies or disorders of the parathyroid axis, such as in patients with previous surgery or autoimmune destruction of the parathyroid gland. Hypercalcemia (above 2.5 mmol/L total calcium or 1.3 mmol/L ionized) in primary care is commonly associated with dehydration, primary hyperparathyroidism, and malignancy such as multiple myeloma. When hypercalcemia is severe, generally defined as total calcium above 3.5 mmol/L or ionized calcium above 2.0 mmol/L, therapy should be initiated immediately. Values of calcium below this threshold but above 3.0 mmol/L total calcium or 1.75 mmol/L ionized are considered moderate hypercalcemia and patients with calcium values in this range may not need immediate therapy but should be monitored closely. Precise values of normal ranges and cut offs may vary between laboratories.

Serum Calcium Level

It remains common practice to apply the Payne formula (usually expressed as albumin-adjusted calcium (mmol/L) = total calcium (mmol/L) + 0.02 [40 – albumin (g/L)]) (1) to adjust total calcium. This correction is intended to enhance the ability of the total calcium concentration to serve as a marker of the physiologically relevant parameter, ionized calcium, in patients with hypoalbuminemia.

Since the original Payne paper, clinical use of this correction formula has spread such that many clinicians routinely apply this ‘correction’ to all total calcium measurements. This observation is supported by data available from Vancouver Coastal Health and Providence Health Care laboratories. In 2018, total serum calcium and albumin were ordered together 72% of the time, suggesting that many clinicians believe that serum albumin measurement is required in order to interpret total calcium concentrations.

There are a number of problems with the Payne formula. This formula was derived in 200 patients whom Payne considered to be unlikely to have abnormalities of ionized calcium, however 20% of the patients had hyperproteinemia secondary to multiple myeloma. Payne et al relied upon results from a single laboratory which used methodologies for the measurement of albumin and total calcium which are different from methods in routine use today. The formula was designed to transform the calcium results in those patients who had hypoalbuminemia so that the distribution of results would match the distribution of calcium results in the patients with normal serum albumin concentrations. There was no validation of the formula using ionized calcium, which was not measured.

What data addresses this gap

There is considerable evidence (2-12) that application of the Payne formula tends to misclassify the calcium status of patients and performs less well than simply evaluating uncorrected total calcium. Payne himself recently wrote a letter to the editor (13) in which he acknowledged that his original formula is not universally applicable, requiring modification for the specific albumin assay in use by a laboratory, and that any albumin-based adjustment will likely overestimate calcium in patients with renal failure. In renal failure, the albumin concentration is underestimated when uremia induced carbamylation of albumin reduces its detection by the assay (14). Attempts to derive a new formula (10-12) to improve upon the performance of the Payne formula have failed to find a correction which performs significantly better than unadjusted total calcium.

The physiological basis for the albumin adjustment is the theory that when albumin is reduced, the amount of calcium bound to albumin is also reduced, such that the total serum calcium may be low despite a normal ionized calcium concentration. However, this physiologic basis is belied by evidence that in hypoalbuminaemic states, the binding constant between albumin and calcium changes, and more calcium binds to each available gram of albumin (15). Formulae such as the Payne formula which assume a constant relationship between albumin concentration and the fraction of calcium which is bound to albumin are thus expected to overestimate ionized calcium in patients with low albumin. Several studies have borne out this tendency of correction formulae to overestimate ionized calcium.

Steen et al (2) found that in patients with albumin <30 g/L, 75% of patients classified as normocalcemic using the Payne formula in fact had hypocalcemia based on ionized calcium levels. Another study (3) found that adjusted calcium values derived by applying the Payne formula agreed with ionized calcium levels in only 55-65% of patients. In contrast, unadjusted total calcium correctly categorized 70-80% of patients. Agreement between adjusted calcium and ionized calcium was even worse for patients with renal impairment (eGFR<60 min/mL/1.73m2). The adjustment significantly overestimated calcium concentrations in these patients. A similar trend has been documented in critically ill patients in both the medical and surgical ICU settings (4-6).

The poor performance of the calcium correction has also been observed in the hypoalbuminemic geriatric population (7). Again, the correction impairs the sensitivity of the corrected result to detect true hypocalcemia. The more severe the hypoalbuminemia, the poorer the performance of the adjustment formula. This has also been demonstrated in stable hemodialysis patients (8-9).

Other studies (10-11) have sought to derive new formulae for the purpose of correcting calcium for albumin concentration. James et al (10) considered many possible formulae but ultimately concluded that if any adjustment is to be made to calcium to account for hypoalbuminemia, the adjustment formula must be locally derived.

Many of the studies above were done in hospital inpatients. Less data is available in outpatients, as ionized calcium is more difficult to measure in this population due to the requirement that specimens for ionized calcium be analyzed promptly after collection (16). However, a study which examined results from both inpatients and outpatients of a hospital and excluded critically ill patients (12) confirmed that unadjusted total calcium performs better than any of the available correction formulae (including those put forth by Payne and James) in ROC analysis compared to the ionized calcium gold standard.

What I recommend (practice tips)

Formulae to adjust total calcium for the albumin concentration should be abandoned. The use of these formulae overestimates ionized calcium in patients with hypoalbuminemia, causing false negatives for hypocalcemia and false positives for hypercalcemia. Measurement of ionized calcium is now relatively inexpensive and is available in most hospitals and many outpatient settings.

  1. Measurement of ionized calcium is recommended over total calcium when calcium homeostasis is in question.
  2. If calcium is ordered as a ‘screening’ test without specific clinical suspicion for a disorder of calcium homeostasis, it is reasonable to assess unadjusted total calcium. If this level is abnormal, confirmation with ionized calcium may be sought prior to further workup or therapy.
  3. Where ionized calcium is not available, total calcium should be assessed without the application of any correction formula.
  4. Order serum albumin only if clinically indicated for reasons other than adjusting total calcium.

References

  1. Payne RB, Little AJ, Williams RB, Milner JP. Interpretation of serum calcium in patient with abnormal serum proteins. Br Med J. 1973;4:643-646. DOI: 10.1136/bmj.4.5893.643. (View)
  2. Steen O, Clase C, Don-Wauchope A. Corrected calcium formula in routine clinical use does not accurately reflect ionized calcium in hospital patients. Canad J Gen Int Med. 2016;11(3):14-21. DOI: 10.22374/cjgim.v11i3.150. (View)
  3. Smith JD, Wilson S, Schneider HG. Misclassification of calcium status based on albumin-adjusted calcium studies in a tertiary hospital setting. Clin Chem. 2018;64(12):1713-1722. DOI: 10.1373/clinchem.2018.291377. (Request with CPSBC or view with UBC)
  4. Slomp J, van der Voort PH, Gerritsen RT, Berk JA, Bakker AJ. Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill. Crit Care Med. 2003;31:1389-1393. DOI: 10.1097/01.CCM.0000063044.55669.3C. (View with CPSBC or UBC)
  5. Dickerson RN, Alexander KH, Minard G, Croce MA, Brown RO. Accuracy of methods to estimate ionized and “corrected” serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr. 2004;28(3):133-141. DOI: 10.1177/0148607104028003133. (Request with CPSBC or view with UBC)
  6. Byrnes MC, Hunyh K, Helmer SD, et al. A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. Am J Surg. 2005;189(3):310-314. DOI: 10.1016/j.amjsurg.2004.11.017. (View with CPSBC or UBC)
  7. Sorva A. ‘Correction’ of serum calcium values for albumin biased in geriatric patients. Arch Geron Geri. 1992;15(1):59-69. DOI: 10.1016/0167-4943(92)90040-B. (Request with CPSBC or view with UBC)
  8. Clase CM, Norman GL, Beecroft ML, Churchill DN. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant. 2000;15:1841-1846. DOI: 10.1093/ndt/15.11.1841. (Request with CPSBC or view with UBC)
  9. Gouri A, Dekaken A. A comparison of corrected serum calcium levels to ionized calcium levels in haemodialysis patients. Ann Biol Clin (Paris). 2012;70:210-212. DOI: 10.1684/abc.2012.0693. (Request with CPSBC or view with UBC)
  10. James MT, Zhang J, Lyon AW, et al. Derivation and internal validation of an equation for albumin-adjusted calcium. BMC Clin Pathol. 2008;8:12. DOI: 10.1186/1472-6890-8-12. (View)
  11. Antonio JM. New predictive equations for serum ionized calcium in hospitalized patients. Med Princ Pract. 2016;25:219-226. DOI: 10.1159/000443145. (View)
  12. Lian IA, Asberg A. Should total calcium be adjusted for albumin? A retrospective observational study of laboratory data from central Norway. BMJ Open. 2018;8:e017703. (View)
  13. Grzych G, Pekar JD, Durand G, Deckmyn B, Maboudou P, Lippi G. Albumin-adjusted calcium and ionized calcium for assessing calcium status in hospitalized patients. Clin Chem. 2019;65(5). DOI: 10.1373/clinchem.2018.300392. (Request with CPSBC or view with UBC)
  14. Kok MB, Tegelaers Fp, van Dam B, van Rijn JL, van Pelt J. Carbamylation of albumin is a cause for discrepancies between albumin assays. Clinica Chimica Acta. 2014;434:6-10. DOI: 10.1016/j.cca.2014.03.035. (View with CPSBC or UBC)
  15. Besarab A, Caro JF. Increased absolute calcium binding to albumin in hypoalbuminaemia. J Clin Pathol. 1981;34:1368-1374. DOI: 10.1136/jcp.34.12.1368. (View)
  16. Glendenning P. It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurement. Ann Clin Biochem. 2013;50:191-193. DOI: 10.1177/0004563213482892. (View with CPSBC or UBC)
  17. Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician. 2003;67:1959-1966. (View with CPSBC or UBC)



Elevated anti-Thyroglobulin Antibodies

HOSP # WARD Oudtshoorn Clinic
CONSULTANT George van der Watt & David Marais DOB/AGE 66y Male

Abnormal Result

Presenting Complaint

Mr. X, a 66 year old male, complained of chest pain, was seen at the Oudtshoorn Emergency department and a myocardial infarction was excluded by three serial point-of-care (POC) Troponin I results.

History

  • Known with hypothyroidism, but the cause was not defined yet.
  • On Eltroxin 150 ug daily PO
  • No other treatment.
  • Various stool analyses had been sent in for culture, with no definitive result.

Examination

Unfortunately not known.

Laboratory Investigations

Free T4: 24.6 pmol/L (7.6 – 16.1 pmol/L)

Anti-Thyroglobulin Antibody levels were elevated at 1944 U/mL (ref. <115 U/mL).

Other Investigations

Later, by retrospective viewing of the patient’s results it was revealed:

Total Cholesterol (TC) was elevated at 7.6 mmol/L. Hypothyroidism is associated with hypercholesterolemia. It can be concluded by the retrospective overview of results that upon an episode of hypothyroidism, the patient had hypercholesterolemia. This was most likely due to cessation of Thyroxine treatment, to whatever reason.

Index sample marked by the yellow shade. TC result which is raised (upper left corner) corresponds to the severely hypothyroid episode as revealed by the low T4 on that same sample.

Investigations also confirmatory for auto-immune hypothyroidism are:

  • Anti-Thyroid peroxidase antibodies
  • Anti-TSH receptor antibodies

Final Diagnosis

Auto-immune hypothyroidism

Take Home Messages

Interestingly, numerous patients with hypothyroidism is diagnosed at our Lipid Clinic at Groote Schuur Hospital. Patients are being referred for hypercholesterolaemia. Generally referral to this clinic happens when TC > 7.5 mmol/L. These patients are referred as presumed to have familial hypercholesterolaemia, but upon further work-up it is found that many of these patients have long-standing untreated hypothyroidism.

Prevalences of antithyroid antibodies as summarized by Up-to-date:

Image result for auto-immune hypothyroidism antibodies"



Thyroid Carcinoma

HOSP # WARD Nuclear Medicine
CONSULTANT   DOB/AGE 62 y Female

Abnormal Result

Thyroglobulin value of <0.1 ug/L upon signing results out.

Presenting Complaint

Patient presented with a neck “swelling” in October 2016. Systemic complaints were not inquired, but none was reported.

History

TFT: euthyroid since presentation when the thyroid functions were first tested in 2016.

Examination

A solitary thyroid nodule was found in the neck, moving with swallowing.

Laboratory Investigations

TFT: euthyroid upon presentation, which is clear from the table below.

  07/11/2019 08/08/2019 21/06/2019 20/02/2019 20/11/2018 26/09/2018 21/09/2018 05/07/2018 13/06/2018 29/05/2018 07/05/2018 08/01/2018 05/04/2017 26/10/2016
TSH δ- 1,49   δ- 7,07 H δ+62,97 H  0.01 L δ- 0.01 L        δ+88,52 H  3,84    6,35 H δ+ 9,88 H  2,86    4,05   δ+ 3,26    1,62  
Free T4  21,4   δ+ 22,3 H δ-  3.0 L δ- 29,8 H δ+ 42,7 H        δ-  3,1 L  17,3   CEGK  15,1                 δ+ 14,9      12  
Free T3                                                                                       4,8         
Thyroglobulin (3.5-77.0 ug/L)  <0.1 L  <0.1 L   0.1 L  <0.1 L δ- <0.1 L   7,9            8,8     7,6                                     
Anti-thyroglobulin Ab (<115 U/ml)   <10     <10     <10     <10     <10      11             14      11                                     

From results above it can be seen that the patient was euthyroid upon presentation (in 2016 and later until excision – highlighted in bold)

Hemithyroidectomy was done in May 2018, and another hemithyroidectomy in September 2018, thus the thyroglobulin after the first and second surgery was still detectable, but absent after September 2018.

Other Investigations

Ultrasound upon first presentation was indicative of a “suspicious nodule” in the thyroid gland.

Final Diagnosis

PATHOLOGICAL DIAGNOSIS – excision biopsy of nodule (17/01/2018)

Specimen A:
Right lobe of thyroid, hemithryoidectomy:
Encapsulated follicular variant of papillary thyroid carcinoma
Specimen B:
Right cervical lymph node (Level VI), biopsy:
Negative for malignancy (0/1)

PATHOLOGICAL DIAGNOSIS – left thyroid lobectomy (11/05/2018):

Left lobe of thyroid, excision: Negative for malignancy

PATHOLOGICAL DIAGNOSIS:

Right thyroid, lobectomy: Negative for malignancy (05/09/2018):

Take Home Messages

  • Thyroglobulin level is directly proportional to thyroid tissue present in vivo, hence is a useful tumour marker for thyroid cancer.
  • Anti-thyroglobulin antibody level is tested with Thyroglobulin to exclude false low values of thyroglobulin. If Anti-thyroglobulin Ab levels are increased with a decreased thyroglobulin level, the decrease in tumour marker is likely due to immunological clearance of the thyroglobulin and the result is hence likely false. This is the reason for the following canned text in TrakCare when the thyroglobulin level measures low:

The presence of thyroglobulin antibodies may interfere with the
thyroglobulin assay. The result of this test must be treated with reserve
if the patient has a positive thyroglobulin antibody test.

TrakCare canned text for low thyroglobulin

  • Upon total removal of the thyroid, thyroid replacement therapy is necessary, preferably slightly hyperthyroid levels to suppress TSH, and hence prevent tumour growth, as is also evidenced by this patient’s TSH and free T4 results.
  • As with most other tumour markers, thyroglobulin should be used for follow-up as a proxy of tumour size or regression.